Process of using chlorine dioxide for the attenuation and/or treatment of Coronavirus diseases such as COVID-19 and disabling, treating or attenuating the SARS CoV-2 virus, and its future infective variants

Abstract

The use of chlorine dioxide (CLO2) to kill or disable pathogens such as viruses, particularly those of the Coronavirus family. A certain amount of CLO2 is used via different modalities, particularly through one's nose or mouth, as a therapeutic. CLO2 can treat, cure and / or prevent diseases, such as methicillin resistant Staphylococcus aureus (MRSA), fungal infections, the common cold, and more particularly a current disease in the year 2020, known as COVID-19. The invention will not only kill or disable SARS CoV-2, which causes COVID-19, but will also kill or disable the next Coronavirus, SARS CoV-3, once CoV-2 mutates and escapes any vaccine against it.

Description

[0001]Process of using chlorine dioxide solution as a safe and effective therapy for the prevention and or treatment of the Coronavirus family of diseases such as the common cold, and COVID-19, and for killing the SARS CoV-2 virus, its future mutants and diseases via the nasal and sinus passages of the upper respiratory tract and lungs of the lower respiratory tract via one's nose.BACKGROUND OF THE INVENTION[0002]As the world goes more into entropy, diseases become more and more difficult to cope with and to treat, particularly as they spread wildly and become immune to our modern medicines. Microbes mutate into novel pathogens that have never before been seen. A perfect example is the new SARS CoV-2. It is very contagious, even though it is not as deadly as its matriarch, SARS CoV. It is currently believed that the SARS CoV-2 from the spring of 2020 has now mutated and is now more contagious as of the fall of 2020.[0003]It takes time to develop treatments such as antibiotics and va...

AI Technical Summary

Benefits of technology

The invention relates to a therapeutic called CLO2 that can kill or disable pathogens, including coronaviruses, and expose them so other therapeutics or vaccines can work more efficiently. CLO2 is non-irritating, non-inflammatory, and can infiltrate, penetrate, and diffuse into multiple areas. It is also inexpensive and does not require refrigeration or freezing. The therapeutic works by oxidizing pathogens through biofilm control, which makes it particularly useful for killing pathogens in the nasal and sinus cavities and keeping blood purified for transfusions. The invention also relates to a method of disabling the spike protein of SARS CoV-2, which allows the virus to be exposed to the human immune system and develop antibodies against it.

Problems solved by technology

One third of patients do not have any signs or symptoms such as malaise, cough, or sore throat, and fever is absent in 75% of people during this phase and are not able to detect anything being wrong.